Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Dova’s Doptelet Gets First-To-Market Edge In Thrombocytopenia, Ahead Of Shionogi

5 hours 35 min ago

Dova CEO Alex Sapir very confident of oral thrombopoietin receptor antagonist’s chances of taking market share from current standard of...

      Related Stories 

Diurnal Adrenal Franchise Takes Shape With Alkindi Launch

10 hours 13 min ago

With the launch in Germany of Alkindi, Diurnal has kickstarted its plan of offering therapies that treat patients with cortisol...

      Related Stories 

Tomorrow’s CRO Steps Into The Real World

12 hours 13 min ago

Last year, 187 deals took place in the pharma services realm, each one molding the acquisitive company into a slightly...

      Related Stories 

Missing In Action: China’s Best Shot In Ebola Vaccine Race

Mon, 05/21/2018 - 10:40pm

As the Congo grapples with the latest outbreak of Ebola, China has approved its first domestically developed vaccine in record...

      Related Stories 

Nabriva On Pace For Lefamulin NDA; Stock Tumbles Despite Trial Success

Mon, 05/21/2018 - 2:10pm

With a pair of Phase III trials demonstrating lefamulin’s non-inferiority to moxifloxacin in CABP, Nabriva plans to file an NDA...

      Related Stories 

Phase III Beckons For A Short-Course Seasonal Allergic Rhinitis Jab

Mon, 05/21/2018 - 1:58pm

A marketing approval for a seasonal allergic rhinitis vaccine from Allergy Therapeutics has moved nearer with positive top-line Phase II...

      Related Stories 

Takeda-Shire In India: Sleeping Giant?

Mon, 05/21/2018 - 8:08am

Will Takeda take a less measured approach in India, where Shire brings it a significant on-market portfolio? Scrip...

      Related Stories 

Takeda Looks To The New As It Braces For Velcade Generics

Sun, 05/20/2018 - 8:27pm

Takeda is facing major revenue challenges from US generics to its big seller Velcade, but is looking to successor and...

      Related Stories 

FDA Flags Lower Efficacy For Merck's Keytruda, Roche's Tecentriq In Frontline Bladder Cancer Trials

Fri, 05/18/2018 - 4:22pm

In patients with previously untreated metastatic bladder cancer with low PD-L1 expression, PD-1 drugs alone don't work as well as...

      Related Stories 

Pipeline Watch: Phase III Progress With Burosumab, Duvelisib And Galcanezumab

Fri, 05/18/2018 - 8:44am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Will Glenmark-Celon’s ‘Substitutable’ Seretide Deliver In Europe?

Fri, 05/18/2018 - 8:28am

Glenmark-Celon’s generic Seretide Accuhaler dry powder inhaler (DPI) has hit the Danish market but whether it can build momentum around...

      Related Stories 

More Alzheimer's Pain As J&J Pulls Plug On BACE Inhibitor

Fri, 05/18/2018 - 8:21am

J&J's Janssen unit is ending development of atabecestat after serious elevations of liver enzymes were seen in some patients who...

      Related Stories 

Mehta Analysis: Trump Pricing Tempest In a Teapot Is An Opportunity For Biopharma Leaders

Fri, 05/18/2018 - 4:44am

President Trump's much anticipated pronouncements on drug pricing reform leave a lot to be clarified. Biopharma companies and their leaders...

      Related Stories